InfuSystem cites DME as part of ‘future success’
By HME News Staff
Updated 9:20 AM CDT, Thu August 12, 2021
ROCHESTER HILLS, Mich. – InfuSystem reported second quarter net revenues of $24.8 million, a decrease of 4% compared to the same quarter a year ago.
Integrated Therapy Service net revenue was $16.3 million, an increase of 5% vs. prior year; DME Services net revenue was $8.5 million, a decrease of 18%; and Pain Management and Negative Pressure Wound Therapy combined net revenues increased 114%.
“2021 is proving to be a very dynamic year for InfuSystem and the health care sectors in which we operate,” said Rich Dilorio, CEO. “The keys to our future success are the investments we are making to elevate both our ITS and DME segments to expand our future opportunity and growth potential. In addition to the two previously announced acquisitions of small biomedical services companies, we have materially accelerated the hiring of experienced sales professionals into our NPWT and Pain Management ITS businesses.”
In June, InfuSystem announced it had entered into a joint agreement with Bio Compression Systems to add lymphedema therapy.
Comments